Skip to main navigation

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Investors
Join Us
Contact Us

Press Releases

Year

November 22, 2021

Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss

November 10, 2021

Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update

November 8, 2021

Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit

October 20, 2021

Decibel Therapeutics to Present at the Jefferies Gene Therapy/Editing Summit

September 30, 2021

Decibel Therapeutics Announces Publication of Foundational Study of Noise-related Inner Ear Damage

September 9, 2021

Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss

September 2, 2021

Decibel Therapeutics to Present at Upcoming Investor Conferences

August 18, 2021

Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary

August 10, 2021

Decibel Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update

June 2, 2021

Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directors

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 22

Shareholder Tools

Contact IR
Contact IR

Email Alerts
Email Alerts

Print Page
Print Page

RSS Feeds
RSS Feeds

Search
Search

© Decibel Therapeutics, Inc. 2021. All rights reserved.

Privacy Notice
Terms of Use

Twitter
LinkedIn

Main Corporate Nav

About Us
The Need
Our Approach
Pipeline
Investors
Join Us
Contact Us